Submissions

Login or Register to make a submission.

Author Guidelines

Authors are invited to make a submission to this journal. All submissions will be assessed by an editor to determine whether they meet the aims and scope of this journal. Those considered to be a good fit will be sent for peer review before determining whether they will be accepted or rejected.

Before making a submission, authors are responsible for obtaining permission to publish any material included with the submission, such as photos, documents and datasets. All authors identified on the submission must consent to be identified as an author. Where appropriate, research should be approved by an appropriate ethics committee in accordance with the legal requirements of the study's country.

An editor may desk reject a submission if it does not meet minimum standards of quality. Before submitting, please ensure that the study design and research argument are structured and articulated properly. The title should be concise and the abstract should be able to stand on its own. This will increase the likelihood of reviewers agreeing to review the paper. When you're satisfied that your submission meets this standard, please follow the checklist below to prepare your submission.

Author Guidelines for JBNC

INTRODUCTION

The Journal of Birgunj Nursing Campus (JBNC) is an official, peer-reviewed Journal of Birgunj Nursing Campus. It is published annually and accepts articles in the following categories:

  • Original Articles,
  • Review Articles,
  • Case Report,
  • Viewpoints, short communications
  • Letter to the Editor and others.

Authors do not have to pay for submission, processing or publication of articles at JBNC.

SCOPE OF THE JOURNAL

The journal publishes articles related to research in the field of nursing sciences and biomedical sciences related to all the disciplines of the medical sciences, medical education, public health, health policy, and health care management, including ethical and social issues about health and wellbeing. The journal gives preference to good quality research papers with novel findings, and clinically oriented studies over experimental and animal studies.

THE EDITORIAL PROCESS

Manuscripts will be submitted to JBNC and reviewed for possible publication, provided they have not already been published elsewhere, submitted concurrently, or already accepted for publication. A manuscript may be rejected by an editor before formal peer review begins. Editors first review all submitted manuscripts. Submitters will be notified of the reviewer's comments and the acceptance or rejection of their manuscript.Accepted articles will be edited for grammar, punctuation, typographic style, and formatting. Proofs will be sent to the corresponding author and must be returned within 5 days. Non-response to the proof copy may delay the publication of the same article or may even result in rejection by the journal.

THE PEER REVIEW PROCESS

The manuscript will be sent to two expert reviewers who are blind to the identity of the authors for careful review, input, and comments. The final decision to accept or reject an article is based on the Editor-in-Chief and reviewers. Authors will be notified of manuscript rejection/acceptance along with reviewer comments.An accepted paper must be resubmitted after making any necessary changes or resolving any questions raised during the peer review process. Reviewers are asked to submit their reviews within two weeks.

SUBMISSION GUIDELINES

Types and Word Limits 
JBNC publishes original research, reviews, and discussion articles.The maximum length of a complete paper is 3000 words (excluding references and one word for tables or figures), but short papers are recommended. JBNC also publish short editorials and letters commenting on current content.

Research Papers – 2,000- 3,000 words: JBNC publishes original research that is consistent with the purpose and scope of the journal. Research articles must follow generally accepted reporting standards.

Reviews and Discussion Papers – 2,000-3,000 words: JBNC publish systematic reviews and more comprehensive literature reviews (such as scoping reviews). Systematic reviews should adhere to accepted reporting standards. We welcome contributions that introduce or explain in more detail new or little-used methods or analytical approaches that are of critical importance to the field.

Letters to the Editor - maximum 1000 words:  The Editor invites readers to submit letters that relate to and comment on the journal's current content, to stimulate scholarly discussion and debate. Discussions are directly related to the purpose and scope of the journal or simply report data or research findings that may not warrant a complete essay.

Editorials - maximum 1000 words:  Authors with ideas for editorials dealing with topics of substantive importance to the profession, especially those of a controversial nature or people.

Case reports- Maximum 1000 words:  New cases and interesting/very rare cases with clinical significance or impact can be reported.

Viewpoint- Maximum 800 words: These articles are personal opinions and allow us to express our perspectives on health-related topics.

SUBMISSION PREPARATION CHECKLIST

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors who do not adhere to these guidelines.

  1. The submission has neither been published previously nor is it before another journal for consideration (or an explanation has been provided in comments to the Editor). Submission should be within 5 years time, older submissions will not be proceeded for publication
  2. The submission file is in Microsoft Word document file format.
  3. The text is double-spaced; words are in Times New Roman, uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations and tables are placed within the text at the appropriate points.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author’s Guidelines.
  5. Supplementary Files: Please also submit supplementary files along with your manuscript:
    • Cover letter
    • Authorship letter
    • Ethical Approval letter

TITLE PAGE
The title page must contain:

  1. Types of manuscript (e.g.Original article, Case Report, Review Article, short communication, view points etc.)
  2. A concise but informative title. Capitalize each word. Eg. Knowledge regarding Chronic Kidney Disease among Patients with Hypertension in Tertiary Hospital.(10-20 words in Title of the study)
  3. Each contributor's full name (first name, middle name, last name), their highest degree, and institutional affiliation.
  4. Name, address, telephone number, fax number, and e-mail address of the submitter responsible for correspondence regarding the manuscript.
  5. Total number of pages, total number of tables, figures, photos, and number of words counted separately for the abstract and text (excluding references and abstract).
  6. Sources of support in the form of grants, equipment, medicines, or all of these.
  7. Acknowledgement, if any
  8. If the manuscript was presented at a conference, the organization, location, and exact date of the presentation must be stated.

CONFLICT OF INTEREST NOTIFICATION PAGE
It should be made part of the manuscript to prevent information about potential conflicts of interest from being overlooked or misplaced. However, it must also be included on one other page immediately following the title page.

ABSTRACT
The second page must include the full title and abstract of the manuscript. For original papers, the abstract should be structured as follows:

  • Background
  • Methods
  • Results
  • Conclusion
  • Keywords

Abstracts below must contain 3 to 5 keywords, ordered alphabetically and separated by semicolons. Abstracts should not be configured for review articles and case reports. Do not include references/citations in the abstract. Word limits for abstracts is up to 250 words.

INTRODUCTION
The introduction should provide the context of the study, explaining the nature of the issue and its importance. It should also describe the specific purpose or research objective that the study or hypothesis is being tested for. The research objective is often more focused when presented as a question. Both the primary and secondary objectives should be described, as well as any pre-defined subgroup analyses. Only directly relevant references should be included, and data/conclusions from the work being reported should not be included.

METHODS
The methods section should only include information that was available at the time the study was planned or protocol was written; all information obtained during the conduct of the study belongs to the results section.  Methods should include Study design, Study site and setting and sampling (including if appropriate justification of sample size and power), inclusion and/or exclusion criteria, study interventions (if any), fidelity of intervention (if any), instrument with validity and reliability, data collection and data analysis, ethical considerations, and duration of study in logical order.

RESULTS
The results should be presented in a logical sequence, with the main or most important findings presented first. It is not necessary to repeat all the data in the tables or illustrations in the text; instead, emphasize or summarize only the most important observations. When summarizing data in the results section, provide numeric results not only as derivatives (e.g., percentages) but also as the absolute numbers from which the derivatives were calculated. Additionally, specify the statistical methods used to analyse the data.  Data should be presented in tables, figures and graphs; but data should not be duplicated in both graphs and tables.

DISCUSSION
The discussion should highlight the new and important aspects of the study and conclude them. It should not repeat data or information from the Introduction or Results sections. It is helpful to start the discussion by summarizing the main findings, then, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and clinical practice. The conclusions should be linked to the objectives of the study.

CONCLUSIONS
The conclusions that follow from the findings should be clear and based on the study objectives and results. There should not be any citations or discussion about others’ studies.

CITATION AND REFERENCES
References should be numbered in the order of citation in the text. Authors are instructed to follow the modified Vancouver system for citing scientific literature.

In citation

  1. Superscripts without brackets must be used.
  2. Citations should be inserted before colons and semi-colons. (to the left)
  3. Citation should be inserted after commas and full stops. (to the right)

Reference list

  1. References at the end should be close to Vancouver style.
  2. Include the last names and initials of the authors, the title of the article, and the name of the publications. year published. volume number and inclusive pages.
  3. The source of the references has to be identified by providing the DOI link, full-text links or any other link, after each reference.
  4. If you are using EndNote, submit your manuscript in plain text format.

TABLES AND FIGURES
Tables should be self-explanatory and should not duplicate textual material. Tables with more than 10 columns and 25 rows are not acceptable. Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each. Type or print each table with double spacing on a separate sheet of paper. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Do not use internal horizontal or vertical lines. Give each column a short heading. Authors should place explanatory matter in footnotes, not in the heading. Explain all Non-standard abbreviations in footnotes, and use the following symbols, in sequence:

*, †, ‡, §, ||, ¶, ** , †† ,‡‡

Identify statistical measures of variations, such as standard deviation and standard error of the mean. Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge that source fully. Figures should be numbered consecutively according to the order in which they have been cited in the text.

Only six tables/figures are permitted.

Units of Measurement: Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or litre) or their decimal multiples. Temperatures should be in degrees Celsius.Blood pressure should be in millimetres of mercury unless other units are specifically required by the journal.

Abbreviations and Symbols: Use only standard abbreviations; the use of non-standard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript.

Copyright Transfer and Author Agreement:
Submission of the manuscript means that the authors agree to assign exclusive copyright, which will eventually be transferred to the author. JBNC aims to increase the visibility and ease of use of open-access scientific and scholarly articles, thereby promoting their increased usage and impact. Hence, JBNC grants permission to read, download, copy, distribute, print, search, or link to the full texts of these articles which are available online (http://jbnc.birgunjnursingcampus.com.) freely.

Authorship: All persons designated as authors should qualify for authorship. Authorship credit should be based only on significant contributions. Submission of a manuscript will also be taken to imply that all authors have obtained permission from their employers or institution to publish, if they are obliged to do so and that relevant ethical approval has been obtained for clinical studies. Authorship may include an explanation of each author’s contribution separately.Authorship must include complete information of all the authors with department, institution, email ID, contribution, and signature.

Forwarding letter: The Forwarding letter accompanying the article should contain the name and complete postal address of one author as a correspondent and must be signed by all authors. The correspondence author should notify change of address, if any, on time.

Declaration: A declaration should be submitted stating that the manuscript represents valid work and that neither this manuscript nor one with substantially similar content under the present authorship has been published or is being considered for publication elsewhere and the authorship of this article will not be contested by anyone whose name(s) is/are not listed here, and that the order of authorship as placed in the manuscript is final and accepted by the co-authors. Declarations should be signed by all the authors in the order in which they are mentioned in the original manuscript.

Dual publication: If the material in a submitted article has been published previously or is to appear in part or whole in another publication, the Editor in Chief must be informed. If the same paper appears simultaneously elsewhere or has previously been published or appears in a future publication, then the author will be black-listed for the JBNC, and future articles of the author will be rejected automatically.

Privacy Statement
The names and email addresses entered in JBNC will be exclusively for the stated purposes of the journal and will not be made available for any other purpose or to any other party.

Manuscripts Submission Checklist

By submitting a manuscript, the author agrees to the following:

  1. The manuscript should be original and free from plagiarism.
  2. The manuscript should not be a simultaneous submission or under consideration for publication in another journal.
  3. Authorship should be duly filled and all authors should be aware of authorship. The corresponding author shall be solely responsible in case disputes arise.
  4. Authors will retain the copyright of their articles and the articles will be published with a CC-BY license which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  5. Conflict of interest if any must be mentioned at the end of the manuscript.

 While submitting your manuscript please make sure you have submitted the following documents:

  1. Cover letter
  2. Institutional Review Committee (IRC) approval letter
  3. Original manuscript
  4. Authorship declaration form with all authors' signatures
  5. Supplementary files

 PRESENTATION FORMAT

  1. Double spacing, 12-point font
  2. Margins 2.5 cm from all four sides
  3. The title page contains all the desired information
  4. The title should not contain abbreviations
  5. The abstract page contains the full title of the manuscript and does not use abbreviations
  6. Abstract provided (not more than 250 words for original article and 150 words for case reports)
  7. Structured abstract provided for an original article
  8. Keywords provided (3 to 5 words)
  9. Headings in title case (ALL CAPITALS, not underlined)
  10. References cited in superscript in the text without brackets
  11. References according to the journal’s instructions

TABLES AND FIGURES

  1. Number within specified limits.
  2. No repetition of data in tables/graphs and text
  3. Actual numbers from which graphs were drawn, provided
  4. Figures necessary and of good quality (colour)
  5. Table and figure numbers in Arabic letters
  6. Figure legends provided (not more than 40 words)
  7. Patient's privacy is maintained
  8. Credit notes for borrowed figures/tables provided
  9. Only six tables/figures are permitted.

LANGUAGE AND GRAMMAR

  1. Uniformity in the language
  2. Use correct grammar, punctuation, and word synthesis
  3. Abbreviations spelt out in full for the first time
  4. Numerals from one to nine are spelt out
  5. Numerals at the beginning of the sentence are spelt out
  6. Use abbreviated form only after using the full form when it first appears in the text except for the abstract.
  7. Avoid repetition of the same words and waste words

Submission Preparation Checklist

All submissions must meet the following requirements.

  • This submission meets the requirements outlined in the Author Guidelines.
  • This submission has not been previously published, nor is it before another journal for consideration.
  • All references have been checked for accuracy and completeness.
  • All tables and figures have been numbered and labeled.
  • Permission has been obtained to publish all photos, datasets and other material provided with this submission.

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 9 September 2026)